Latest News- Recombinant Proteins Market: Biotechnology research is expected to lead the Application segment during 2025-2029

The Recombinant Proteins Market is being driven by Increase in chronic diseases

The Recombinant Proteins Market is expected to grow at a CAGR of 10.7% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 899.1 million. In the dynamic and competitive landscape of the recombinant proteins market, companies are forming strategic alliances and collaborations to expand their market shares and introduce innovative product offerings. These collaborations enable businesses to enhance their operations and remain competitive on a global scale. For instance, in January 2024, Core Biogenesis and Nucleus Biologics announced a strategic partnership for the manufacturing and distribution of cost-effective and sustainable recombinant proteins. Such alliances not only lead to increased investments in the market but also result in the development and introduction of advanced recombinant protein products. These collaborations are essential for companies to stay competitive and meet the evolving demands of the market. 

Get more information on Recombinant Proteins Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Application
  • Biotechnology research
  • Drug discovery and development
  • Biopharmaceutical production
  • Others
• End-user
  • Pharma and biotechnology companies
  • Academic and research institutes
  • Others
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Asia
    • China
    • India
    • Japan
    • South Korea
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increase in chronic diseases
• Rising inclination toward biologics and biosimilars
• Technological advancements in production of recombinant proteins

However, the market also witnesses some limitations, which are as follows:

• Complexities in manufacturing, storage conditions, and high costs
• Growing popularity of alternative treatments
• Complicated regulatory framework

Benefits of Buying Global Recombinant Proteins Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Recombinant Proteins Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Recombinant Proteins Market encompasses various aspects, including Biosimilar Approvals, Pricing, and Access, as well as Biosimilar Regulation. Key technologies involve Protein Conjugation and Modification, Characterization Techniques, Biopharmaceutical Analytics, and Validation. GMP Compliance, Packaging, Storage, and Protein Delivery Systems are crucial. Targeted Drug Delivery, Biopharmaceutical Innovation, Development, and Engineering Tools are also significant. Bioprocessing Automation Technology, Optimization Techniques, Manufacturing Efficiency, Sustainability, and Quality Assurance are essential for Biopharmaceutical Production. Protein Formulation Development, Stability Studies, and Biosimilar Lifecycle Management complete the market landscape.

Market Research Overview

In the expansive biotechnology sector, the recombinant proteins market represents a significant segment, encompassing therapeutic proteins, protein engineering, biopharmaceutical manufacturing, cell culture, and downstream processing for protein expression. According to Technavio's market analysis, the global healthcare industry, which includes the revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services, is projected to grow substantially. This expansion will be fueled by demographic trends, such as the increasing global population aging, with nearly one-quarter of the US population and a similar ratio in Europe forecasted to be over 60 years old by 2050 and 2030, respectively.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/